Casa
evades

Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso

Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
Personalized cancer treatment using advanced tumour analysis offers new hope
Study provides new look at why rare cancer often evades treatments
CRISPR in Cancer Therapeutics: CAR T, NK, TCR and Beyond
Study provides new look at why rare cancer often evades treatments
Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy
Study provides new look at why rare cancer often evades treatments
Advances in Lung Cancer Treatment Using Nanomedicines
Study provides new look at why rare cancer often evades treatments
Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery - ScienceDirect
Study provides new look at why rare cancer often evades treatments
Organoids bring new insights into liver cancer •
Study provides new look at why rare cancer often evades treatments
Recent Advances in Nanoparticle-Based Cancer Treatment: A Review
Study provides new look at why rare cancer often evades treatments
Communicable cancer: The mounting evidence
Study provides new look at why rare cancer often evades treatments
New model helps identify mutations that drive cancer, MIT News
Study provides new look at why rare cancer often evades treatments
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
de por adulto (o preço varia de acordo com o tamanho do grupo)